Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for painful diabetic sensorimotor neuropathy
IRCT20250818066904N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic neuropathy comparing Gabapentin + memantine with Gabapentin + placebo (2 arms). Primary endpoints: Nerve conduction study criteria score and Neuropathic pain severity. Started Jun 2026; status: completed.
02
Drugs
memantine
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT20250818066904N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250818066904N1.